Recent Events & Catalysts

AstraZeneca's Oncology Engine Keeps Running Despite Wainua Setback

SeekingAlpha · today

Alnylam Highlights Progress with Neuroscience Programs at AAIC 2026, Showcasing Potential of RNAi in Neurological Disease

Yahoo · today

Alnylam Highlights Neuroscience Progress At AAIC 2026, Initiating Phase 2 APPlauDS Study Of Mivelsiran In Down Syndrome-Associated Alzheimer's While Completing cAPPricorn-1 Enrollment In CAA

Benzinga · today

Morgan Stanley Raises its Price Target on Alnylam (ALNY)

Yahoo · 1d ago

Alnylam Pharmaceuticals' Q2 Results to Determine 2026 Revenue Outlook, BofA Securities Says

Yahoo · 1d ago

Amyloidosis Continues To Fight Back

SeekingAlpha · 1d ago

B of A Securities Maintains Buy on Alnylam Pharmaceuticals, Lowers Price Target to $410

Benzinga · 1d ago

Alnylam Pharmaceuticals (NASDAQ:ALNY) Shows Accelerating Momentum as a High Growth Stock

ChartMill · 1d ago

Departure/appointment of directors or officers, Submission of matters to a vote of security holders

Filed 2026-05-27 · 50d ago

Results of operations (earnings release), Financial statements and exhibits

Filed 2026-04-30 · 77d ago · Material